Eton Pharmaceuticals Inc (ETON) — Cash Flow Reinvestment Rate
Eton Pharmaceuticals Inc (ETON) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting $5.00K (capex $5.00K ) from operating cash flow of $7.25 Million. See ETON free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eton Pharmaceuticals Inc Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Eton Pharmaceuticals Inc across 4 annual periods. For the full cash flow conversion analysis, see ETON cash flow metrics.
Annual Cash Flow Reinvestment Rate for Eton Pharmaceuticals Inc (2022–2025)
Year-by-year capital reinvestment analysis for Eton Pharmaceuticals Inc. See how financially flexible is Eton Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | $333.00K | $10.52 Million | $333.00K | ▼ -99.9% |
| 2024 | 41.32x | $40.04 Million | $969.00K | $26.00K | ▲ +18067.9% |
| 2023 | 0.23x | $1.55 Million | $6.82 Million | $775.00K | ▼ -80.3% |
| 2022 | 1.16x | $5.58 Million | $4.82 Million | $2.79 Million | — |